Fresenius traded at 28.02 this Monday January 23rd, decreasing 0.31 or 1.09 percent since the previous trading session. Looking back, over the last four weeks, Fresenius lost 7.60 percent. Over the last 12 months, its price fell by 21.00 percent. Looking ahead, we forecast Fresenius to be priced at 27.24 by the end of this quarter and at 24.23 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
27.93
Daily Change
-1.41%
Yearly
-21.26%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Akzo Nobel 68.14 -0.70 -1.02% -24.36%
Alcon AG 69.26 0.58 0.84% 2.18%
DSM 120.20 -4.80 -3.84% -28.43%
DaVita Healthcare Partners 80.75 0.43 0.54% -26.18%
E.ON 9.96 0.06 0.61% -16.44%
Fresenius Medical Care 33.60 -0.24 -0.71% -40.00%
Fresenius Medical Care 18.32 0.28 1.55% -43.99%
Fresenius 27.93 -0.40 -1.41% -21.26%
Hikma Pharmaceutical 1,696.00 -3.50 -0.21% -14.45%
Philips 15.47 0.36 2.40% -44.83%
Roche Holding 295.35 1.05 0.36% -14.33%
William Demant Holding 195.90 1.40 0.72% -29.94%
Smith & Nephew PLC 1,146.50 4.00 0.35% -5.48%
Sanofi 89.82 -0.91 -1.00% 1.47%
Novartis 84.76 0.28 0.33% 10.44%
Merck 192.35 4.95 2.64% 1.24%
Lonza Group 491.00 7.00 1.45% -19.82%
GlaxoSmithKline 1,414.00 7.20 0.51% -12.42%
GRIFOLS 12.23 0.09 0.74% -20.40%
GN Store Nord 169.50 -1.05 -0.62% -53.94%
Getinge 232.70 4.90 2.15% -28.00%
Essilor 174.50 0.05 0.03% 4.35%
Beiersdorf 111.40 0.15 0.13% 24.05%
Bayer 55.85 -0.54 -0.96% 11.70%
BASF 52.33 -0.13 -0.25% -18.57%
AstraZeneca 11,150.00 -50.00 -0.45% 34.08%
Givaudan 2,915.00 -41.00 -1.39% -27.40%
RWE 41.40 -0.27 -0.65% 17.88%

Indexes Price Day Year
DE40 15048 14.31 0.10% 0.24%
EU50 4136 16.11 0.39% 2.01%

Fresenius
Fresenius SE & Co KGaA is a Germany-based healthcare group. It operates through four business segments. Fresenius Medical Care runs a global network of dialysis clinics, providing treatment for patients with chronic kidney failure. It also offers dialyzers, dialysis machines and renal pharmaceuticals. Fresenius Kabi specializes in intravenously administered generic drugs (IV drugs), clinical nutrition and infusion therapies. It also supplies hospitals with medical devices and products of transfusion technology. Fresenius Helios is a private hospital operator, with over 130 facilities in Germany, including maximum care hospitals and rehabilitation centers and, through Quironsalud, over 80 hospitals and outpatient centers, as well as approximately 300 Occupational Risk Prevention Centers in Spain. Fresenius Vamed manages projects and provides services for health care facilities worldwide, from development and turnkey construction to maintenance and total operational management.